Found 10 clinical trials
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
The investigators propose to use Belinostat in combination with AZT as consolidation therapy for the treatment of ATLL.
- 1 views
- 15 Jul, 2021
- 1 location
Testing the Addition of an Anti-cancer Drug Lenalidomide to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)
], cyclophosphamide, and doxorubicin hydrochloride [hydroxydaunorubicin hydrochloride], or "EPOCH") in treating adult T-cell leukemia-lymphoma. Lenalidomide may help shrink or slow the growth of adult T-cell leukemia
- 0 views
- 29 May, 2021
- 5 locations
Valemetostat Tosylate (DS-3201b) an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)
-cell leukemia/lymphoma.
- 0 views
- 18 Jul, 2021
- 5 locations
Safety Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
, including multiple myeloma (MM), mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), indolent lymphoma, adult T-cell leukemia-lymphoma (ATL), or chronic lymphocytic
- 0 views
- 16 Jun, 2021
- 3 locations
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly among people from the Caribbean islands, Western Africa, Brazil, Iran, and Japan. Most cases of this disease in the
- 113 views
- 22 Aug, 2021
- 4 locations
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Background Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause. Objective To test if a stem cell transplant can cure or control lymphoma. Also to test if new ways of …
- 3 views
- 23 Sep, 2021
- 2 locations
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor
This is a multicenter phase I clinical study evaluating the safety, tolerability, and efficacy of LCAR-T2C cell agents targeting CD4 in patients with relapsed/refractory CD4-positive T lymphocytic tumors. Thirty-three subjects will be enrolled. Subjects will be pretreated with chemotherapy prior to infusion of CAR T cells: about 5 days before …
- 0 views
- 02 Aug, 2021
- 1 location
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors …
- 52 views
- 05 Aug, 2021
- 42 locations
Tissue Collection for Studies of Lymph Cancer
Background Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditions include multiple myeloma, different types of lymphoma, …
- 205 views
- 12 Sep, 2021
- 1 location
Revlimid Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
-cell leukemia lymphoma (hereinafter referred to as relapsed or refractory Adult T-cell Leukemia Lymphoma (ATLL)). Planned registration period 3 years Planned surveillance period
- 4 views
- 23 Jan, 2021
- 1 location